COVID-19 patients receiving oxygen therapy or experiencing a fever show a reduced volume of gray matter in the frontal-temporal network of the brain.
COVID-19 patients receiving oxygen therapy or experiencing a fever show a reduced volume of gray matter in the frontal-temporal network of the brain.